Reshma Kewalramani - CEO & President, Vertex Pharmaceuticals Inc / Ma

As of February 28, 2022


Reshma Kewalramani Net Worth

  • Net worth is estimated to be at least $14.89M
  • Owns at least 73,754 units of Vertex Pharmaceuticals Inc / Ma stock
  • Sold an estimated value of $12.78M in the last 4 years at Vertex Pharmaceuticals Inc / Ma

Reshma Kewalramani Trading

  • Largest purchase of shares was 10,000 units , worth over $1.96M on August 23, 2021
  • Largest sale of shares was 6,532 units , worth over $1.54M on February 26, 2020
  • In total has made about 24 transactions over 4 years
  • Usually trades in February, with the busiest year in 2019
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Reshma Kewalramani Mailing Address

  • Mailing address is C/o Vertex Pharmaceuticals, Inc. 50 Northern Avenue Boston MA 02210 MA

Vertex Pharmaceuticals Inc / Ma Insider Trading

  • The most recent transaction was 45 units sold on May 18, 2022 by Bastiano Sanna worth over $11.38K
  • In the last 19 years, insiders at Vertex Pharmaceuticals Inc / Ma sold an estimated value of $1.61B and bought an estimated value of $522.29M
  • The most active traders are Joshua Boger, Director,  Paul Silva, SVP & Chief Accounting Officer,  and Amit Sachdev, EVP
  • Insider trading is most common in February, with the busiest year in 2015

VERTEX PHARMACEUTICALS INC / MA Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1